 | • レポートコード：D005-00598 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、肺がん手術の世界市場を広く調査・分析し、今後の市場展望をまとめております。肺がん手術の種類別市場規模（外科用器具、モニタリングおよび可視化システム）、用途別市場規模（葉切除術、スリーブ切除術、局所切除術、肺全摘術、低侵襲手術）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Accuray、Karl Storz、Intuitive Surgical、Angiodynamics、Ackermann Instrumente、Ethicon、Trokamed、Teleflex、Olympus、Scanlan International ・地域別グローバル市場分析 2015年-2020年 ・肺がん手術の北米市場（アメリカ、カナダ、メキシコ） ・肺がん手術のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・肺がん手術のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・肺がん手術の南米市場（ブラジル、アルゼンチン） ・肺がん手術の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：外科用器具、モニタリングおよび可視化システム ・用途別分析：葉切除術、スリーブ切除術、局所切除術、肺全摘術、低侵襲手術 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Lung Cancer Surgery market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.2% in the forecast period of 2020 to 2025 and will expected to reach USD 24820 million by 2025, from USD 20260 million in 2019.
The Lung Cancer Surgery market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Lung Cancer Surgery market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Lung Cancer Surgery market has been segmented into:
Surgical Instruments
Monitoring And Visualization System
By Application, Lung Cancer Surgery has been segmented into:
Lobectomy
Removal Of Sleeve
Regional Excision
Lung Removed All
Minimally Invasive Surgery
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Lung Cancer Surgery market presented in the report. This section sheds light on the sales growth of different regional and country-level Lung Cancer Surgery markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Lung Cancer Surgery market.
The report offers in-depth assessment of the growth and other aspects of the Lung Cancer Surgery market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Lung Cancer Surgery Market Share Analysis
Lung Cancer Surgery competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Lung Cancer Surgery sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Lung Cancer Surgery sales, revenue and market share for each player covered in this report.
The major players covered in Lung Cancer Surgery are:
Accuray
Karl Storz
Intuitive Surgical
Angiodynamics
Ackermann Instrumente
Ethicon
Trokamed
Teleflex
Olympus
Scanlan International
Table of Contents
1 Lung Cancer Surgery Market Overview
1.1 Product Overview and Scope of Lung Cancer Surgery
1.2 Classification of Lung Cancer Surgery by Type
1.2.1 Global Lung Cancer Surgery Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Lung Cancer Surgery Revenue Market Share by Type in 2019
1.2.3 Surgical Instruments
1.2.4 Monitoring And Visualization System
1.3 Global Lung Cancer Surgery Market by Application
1.3.1 Overview: Global Lung Cancer Surgery Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Lobectomy
1.3.3 Removal Of Sleeve
1.3.4 Regional Excision
1.3.5 Lung Removed All
1.3.6 Minimally Invasive Surgery
1.4 Global Lung Cancer Surgery Market by Regions
1.4.1 Global Lung Cancer Surgery Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Lung Cancer Surgery (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Lung Cancer Surgery Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Lung Cancer Surgery Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Lung Cancer Surgery Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Lung Cancer Surgery Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Lung Cancer Surgery Status and Prospect (2015-2025)
2 Company Profiles
2.1 Accuray
2.1.1 Accuray Details
2.1.2 Accuray Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Accuray SWOT Analysis
2.1.4 Accuray Product and Services
2.1.5 Accuray Lung Cancer Surgery Revenue, Gross Margin and Market Share (2018-2019)
2.2 Karl Storz
2.2.1 Karl Storz Details
2.2.2 Karl Storz Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Karl Storz SWOT Analysis
2.2.4 Karl Storz Product and Services
2.2.5 Karl Storz Lung Cancer Surgery Revenue, Gross Margin and Market Share (2018-2019)
2.3 Intuitive Surgical
2.3.1 Intuitive Surgical Details
2.3.2 Intuitive Surgical Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Intuitive Surgical SWOT Analysis
2.3.4 Intuitive Surgical Product and Services
2.3.5 Intuitive Surgical Lung Cancer Surgery Revenue, Gross Margin and Market Share (2018-2019)
2.4 Angiodynamics
2.4.1 Angiodynamics Details
2.4.2 Angiodynamics Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Angiodynamics SWOT Analysis
2.4.4 Angiodynamics Product and Services
2.4.5 Angiodynamics Lung Cancer Surgery Revenue, Gross Margin and Market Share (2018-2019)
2.5 Ackermann Instrumente
2.5.1 Ackermann Instrumente Details
2.5.2 Ackermann Instrumente Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Ackermann Instrumente SWOT Analysis
2.5.4 Ackermann Instrumente Product and Services
2.5.5 Ackermann Instrumente Lung Cancer Surgery Revenue, Gross Margin and Market Share (2018-2019)
2.6 Ethicon
2.6.1 Ethicon Details
2.6.2 Ethicon Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Ethicon SWOT Analysis
2.6.4 Ethicon Product and Services
2.6.5 Ethicon Lung Cancer Surgery Revenue, Gross Margin and Market Share (2018-2019)
2.7 Trokamed
2.7.1 Trokamed Details
2.7.2 Trokamed Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Trokamed SWOT Analysis
2.7.4 Trokamed Product and Services
2.7.5 Trokamed Lung Cancer Surgery Revenue, Gross Margin and Market Share (2018-2019)
2.8 Teleflex
2.8.1 Teleflex Details
2.8.2 Teleflex Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Teleflex SWOT Analysis
2.8.4 Teleflex Product and Services
2.8.5 Teleflex Lung Cancer Surgery Revenue, Gross Margin and Market Share (2018-2019)
2.9 Olympus
2.9.1 Olympus Details
2.9.2 Olympus Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Olympus SWOT Analysis
2.9.4 Olympus Product and Services
2.9.5 Olympus Lung Cancer Surgery Revenue, Gross Margin and Market Share (2018-2019)
2.10 Scanlan International
2.10.1 Scanlan International Details
2.10.2 Scanlan International Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Scanlan International SWOT Analysis
2.10.4 Scanlan International Product and Services
2.10.5 Scanlan International Lung Cancer Surgery Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Lung Cancer Surgery Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Lung Cancer Surgery Players Market Share
3.2.2 Top 10 Lung Cancer Surgery Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Lung Cancer Surgery Revenue and Market Share by Regions
4.2 North America Lung Cancer Surgery Revenue and Growth Rate (2015-2020)
4.3 Europe Lung Cancer Surgery Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Lung Cancer Surgery Revenue and Growth Rate (2015-2020)
4.5 South America Lung Cancer Surgery Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Lung Cancer Surgery Revenue and Growth Rate (2015-2020)
5 North America Lung Cancer Surgery Revenue by Countries
5.1 North America Lung Cancer Surgery Revenue by Countries (2015-2020)
5.2 USA Lung Cancer Surgery Revenue and Growth Rate (2015-2020)
5.3 Canada Lung Cancer Surgery Revenue and Growth Rate (2015-2020)
5.4 Mexico Lung Cancer Surgery Revenue and Growth Rate (2015-2020)
6 Europe Lung Cancer Surgery Revenue by Countries
6.1 Europe Lung Cancer Surgery Revenue by Countries (2015-2020)
6.2 Germany Lung Cancer Surgery Revenue and Growth Rate (2015-2020)
6.3 UK Lung Cancer Surgery Revenue and Growth Rate (2015-2020)
6.4 France Lung Cancer Surgery Revenue and Growth Rate (2015-2020)
6.5 Russia Lung Cancer Surgery Revenue and Growth Rate (2015-2020)
6.6 Italy Lung Cancer Surgery Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Lung Cancer Surgery Revenue by Countries
7.1 Asia-Pacific Lung Cancer Surgery Revenue by Countries (2015-2020)
7.2 China Lung Cancer Surgery Revenue and Growth Rate (2015-2020)
7.3 Japan Lung Cancer Surgery Revenue and Growth Rate (2015-2020)
7.4 Korea Lung Cancer Surgery Revenue and Growth Rate (2015-2020)
7.5 India Lung Cancer Surgery Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Lung Cancer Surgery Revenue and Growth Rate (2015-2020)
8 South America Lung Cancer Surgery Revenue by Countries
8.1 South America Lung Cancer Surgery Revenue by Countries (2015-2020)
8.2 Brazil Lung Cancer Surgery Revenue and Growth Rate (2015-2020)
8.3 Argentina Lung Cancer Surgery Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Lung Cancer Surgery by Countries
9.1 Middle East & Africa Lung Cancer Surgery Revenue by Countries (2015-2020)
9.2 Saudi Arabia Lung Cancer Surgery Revenue and Growth Rate (2015-2020)
9.3 UAE Lung Cancer Surgery Revenue and Growth Rate (2015-2020)
9.4 Egypt Lung Cancer Surgery Revenue and Growth Rate (2015-2020)
9.5 South Africa Lung Cancer Surgery Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Lung Cancer Surgery Revenue and Market Share by Type (2015-2020)
10.2 Global Lung Cancer Surgery Market Forecast by Type (2019-2024)
10.3 Surgical Instruments Revenue Growth Rate (2015-2025)
10.4 Monitoring And Visualization System Revenue Growth Rate (2015-2025)
11 Global Lung Cancer Surgery Market Segment by Application
11.1 Global Lung Cancer Surgery Revenue Market Share by Application (2015-2020)
11.2 Lung Cancer Surgery Market Forecast by Application (2019-2024)
11.3 Lobectomy Revenue Growth (2015-2020)
11.4 Removal Of Sleeve Revenue Growth (2015-2020)
11.5 Regional Excision Revenue Growth (2015-2020)
11.6 Lung Removed All Revenue Growth (2015-2020)
11.7 Minimally Invasive Surgery Revenue Growth (2015-2020)
12 Global Lung Cancer Surgery Market Size Forecast (2021-2025)
12.1 Global Lung Cancer Surgery Market Size Forecast (2021-2025)
12.2 Global Lung Cancer Surgery Market Forecast by Regions (2021-2025)
12.3 North America Lung Cancer Surgery Revenue Market Forecast (2021-2025)
12.4 Europe Lung Cancer Surgery Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Lung Cancer Surgery Revenue Market Forecast (2021-2025)
12.6 South America Lung Cancer Surgery Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Lung Cancer Surgery Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Lung Cancer Surgery Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Lung Cancer Surgery by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Lung Cancer Surgery Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Lung Cancer Surgery Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Accuray Corporate Information, Location and Competitors
Table 6. Accuray Lung Cancer Surgery Major Business
Table 7. Accuray Lung Cancer Surgery Total Revenue (USD Million) (2017-2018)
Table 8. Accuray SWOT Analysis
Table 9. Accuray Lung Cancer Surgery Product and Solutions
Table 10. Accuray Lung Cancer Surgery Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Karl Storz Corporate Information, Location and Competitors
Table 12. Karl Storz Lung Cancer Surgery Major Business
Table 13. Karl Storz Lung Cancer Surgery Total Revenue (USD Million) (2018-2019)
Table 14. Karl Storz SWOT Analysis
Table 15. Karl Storz Lung Cancer Surgery Product and Solutions
Table 16. Karl Storz Lung Cancer Surgery Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Intuitive Surgical Corporate Information, Location and Competitors
Table 18. Intuitive Surgical Lung Cancer Surgery Major Business
Table 19. Intuitive Surgical Lung Cancer Surgery Total Revenue (USD Million) (2017-2018)
Table 20. Intuitive Surgical SWOT Analysis
Table 21. Intuitive Surgical Lung Cancer Surgery Product and Solutions
Table 22. Intuitive Surgical Lung Cancer Surgery Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Angiodynamics Corporate Information, Location and Competitors
Table 24. Angiodynamics Lung Cancer Surgery Major Business
Table 25. Angiodynamics Lung Cancer Surgery Total Revenue (USD Million) (2017-2018)
Table 26. Angiodynamics SWOT Analysis
Table 27. Angiodynamics Lung Cancer Surgery Product and Solutions
Table 28. Angiodynamics Lung Cancer Surgery Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Ackermann Instrumente Corporate Information, Location and Competitors
Table 30. Ackermann Instrumente Lung Cancer Surgery Major Business
Table 31. Ackermann Instrumente Lung Cancer Surgery Total Revenue (USD Million) (2017-2018)
Table 32. Ackermann Instrumente SWOT Analysis
Table 33. Ackermann Instrumente Lung Cancer Surgery Product and Solutions
Table 34. Ackermann Instrumente Lung Cancer Surgery Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Ethicon Corporate Information, Location and Competitors
Table 36. Ethicon Lung Cancer Surgery Major Business
Table 37. Ethicon Lung Cancer Surgery Total Revenue (USD Million) (2017-2018)
Table 38. Ethicon SWOT Analysis
Table 39. Ethicon Lung Cancer Surgery Product and Solutions
Table 40. Ethicon Lung Cancer Surgery Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Trokamed Corporate Information, Location and Competitors
Table 42. Trokamed Lung Cancer Surgery Major Business
Table 43. Trokamed Lung Cancer Surgery Total Revenue (USD Million) (2017-2018)
Table 44. Trokamed SWOT Analysis
Table 45. Trokamed Lung Cancer Surgery Product and Solutions
Table 46. Trokamed Lung Cancer Surgery Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Teleflex Corporate Information, Location and Competitors
Table 48. Teleflex Lung Cancer Surgery Major Business
Table 49. Teleflex Lung Cancer Surgery Total Revenue (USD Million) (2017-2018)
Table 50. Teleflex SWOT Analysis
Table 51. Teleflex Lung Cancer Surgery Product and Solutions
Table 52. Teleflex Lung Cancer Surgery Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Olympus Corporate Information, Location and Competitors
Table 54. Olympus Lung Cancer Surgery Major Business
Table 55. Olympus Lung Cancer Surgery Total Revenue (USD Million) (2017-2018)
Table 56. Olympus SWOT Analysis
Table 57. Olympus Lung Cancer Surgery Product and Solutions
Table 58. Olympus Lung Cancer Surgery Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Scanlan International Corporate Information, Location and Competitors
Table 60. Scanlan International Lung Cancer Surgery Major Business
Table 61. Scanlan International Lung Cancer Surgery Total Revenue (USD Million) (2017-2018)
Table 62. Scanlan International SWOT Analysis
Table 63. Scanlan International Lung Cancer Surgery Product and Solutions
Table 64. Scanlan International Lung Cancer Surgery Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Lung Cancer Surgery Revenue (Million USD) by Players (2015-2020)
Table 66. Global Lung Cancer Surgery Revenue Share by Players (2015-2020)
Table 67. Global Lung Cancer Surgery Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Lung Cancer Surgery Revenue Market Share by Regions (2015-2020)
Table 69. North America Lung Cancer Surgery Revenue by Countries (2015-2020)
Table 70. North America Lung Cancer Surgery Revenue Market Share by Countries (2015-2020)
Table 71. Europe Lung Cancer Surgery Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Lung Cancer Surgery Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Lung Cancer Surgery Revenue by Countries (2015-2020)
Table 74. South America Lung Cancer Surgery Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Lung Cancer Surgery Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Lung Cancer Surgery Revenue Market Share by Countries (2015-2020)
Table 77. Global Lung Cancer Surgery Revenue (Million USD) by Type (2015-2020)
Table 78. Global Lung Cancer Surgery Revenue Share by Type (2015-2020)
Table 79. Global Lung Cancer Surgery Revenue Forecast by Type (2021-2025)
Table 80. Global Lung Cancer Surgery Revenue by Application (2015-2020)
Table 81. Global Lung Cancer Surgery Revenue Share by Application (2015-2020)
Table 82. Global Lung Cancer Surgery Revenue Forecast by Application (2021-2025)
Table 83. Global Lung Cancer Surgery Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Lung Cancer Surgery Picture
Figure 2. Global Lung Cancer Surgery Revenue Market Share by Type in 2019
Figure 3. Surgical Instruments Picture
Figure 4. Monitoring And Visualization System Picture
Figure 5. Lung Cancer Surgery Revenue Market Share by Application in 2019
Figure 6. Lobectomy Picture
Figure 7. Removal Of Sleeve Picture
Figure 8. Regional Excision Picture
Figure 9. Lung Removed All Picture
Figure 10. Minimally Invasive Surgery Picture
Figure 11. Global Lung Cancer Surgery Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Lung Cancer Surgery Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Lung Cancer Surgery Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Lung Cancer Surgery Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Lung Cancer Surgery Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Lung Cancer Surgery Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Lung Cancer Surgery Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Lung Cancer Surgery Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Lung Cancer Surgery Revenue Market Share in 2019
Figure 20. Global Top 10 Players Lung Cancer Surgery Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Lung Cancer Surgery Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Lung Cancer Surgery Revenue Market Share by Regions (2015-2020)
Figure 24. Global Lung Cancer Surgery Revenue Market Share by Regions in 2018
Figure 25. North America Lung Cancer Surgery Revenue and Growth Rate (2015-2020)
Figure 26. Europe Lung Cancer Surgery Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Lung Cancer Surgery Revenue and Growth Rate (2015-2020)
Figure 28. South America Lung Cancer Surgery Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Lung Cancer Surgery Revenue and Growth Rate (2015-2020)
Figure 30. North America Lung Cancer Surgery Revenue Market Share by Countries (2015-2020)
Figure 31. North America Lung Cancer Surgery Revenue Market Share by Countries in 2019
Figure 32. USA Lung Cancer Surgery Revenue and Growth Rate (2015-2020)
Figure 33. Canada Lung Cancer Surgery Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Lung Cancer Surgery Revenue and Growth Rate (2015-2020)
Figure 35. Europe Lung Cancer Surgery Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Lung Cancer Surgery Revenue Market Share by Countries in 2019
Figure 37. Germany Lung Cancer Surgery Revenue and Growth Rate (2015-2020)
Figure 38. UK Lung Cancer Surgery Revenue and Growth Rate (2015-2020)
Figure 39. France Lung Cancer Surgery Revenue and Growth Rate (2015-2020)
Figure 40. Russia Lung Cancer Surgery Revenue and Growth Rate (2015-2020)
Figure 41. Italy Lung Cancer Surgery Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Lung Cancer Surgery Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Lung Cancer Surgery Revenue Market Share by Countries in 2019
Figure 44. China Lung Cancer Surgery Revenue and Growth Rate (2015-2020)
Figure 45. Japan Lung Cancer Surgery Revenue and Growth Rate (2015-2020)
Figure 46. Korea Lung Cancer Surgery Revenue and Growth Rate (2015-2020)
Figure 47. India Lung Cancer Surgery Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Lung Cancer Surgery Revenue and Growth Rate (2015-2020)
Figure 49. South America Lung Cancer Surgery Revenue Market Share by Countries (2015-2020)
Figure 50. South America Lung Cancer Surgery Revenue Market Share by Countries in 2019
Figure 51. Brazil Lung Cancer Surgery Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Lung Cancer Surgery Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Lung Cancer Surgery Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Lung Cancer Surgery Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Lung Cancer Surgery Revenue and Growth Rate (2015-2020)
Figure 56. UAE Lung Cancer Surgery Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Lung Cancer Surgery Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Lung Cancer Surgery Revenue and Growth Rate (2015-2020)
Figure 59. Global Lung Cancer Surgery Revenue Share by Type (2015-2020)
Figure 60. Global Lung Cancer Surgery Revenue Share by Type in 2019
Figure 61. Global Lung Cancer Surgery Market Share Forecast by Type (2021-2025)
Figure 62. Global Surgical Instruments Revenue Growth Rate (2015-2020)
Figure 63. Global Monitoring And Visualization System Revenue Growth Rate (2015-2020)
Figure 64. Global Lung Cancer Surgery Revenue Share by Application (2015-2020)
Figure 65. Global Lung Cancer Surgery Revenue Share by Application in 2019
Figure 66. Global Lung Cancer Surgery Market Share Forecast by Application (2021-2025)
Figure 67. Global Lobectomy Revenue Growth Rate (2015-2020)
Figure 68. Global Removal Of Sleeve Revenue Growth Rate (2015-2020)
Figure 69. Global Regional Excision Revenue Growth Rate (2015-2020)
Figure 70. Global Lung Removed All Revenue Growth Rate (2015-2020)
Figure 71. Global Minimally Invasive Surgery Revenue Growth Rate (2015-2020)
Figure 72. Global Lung Cancer Surgery Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Lung Cancer Surgery Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Lung Cancer Surgery Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Lung Cancer Surgery Revenue Market Forecast (2021-2025)
Figure 76. Europe Lung Cancer Surgery Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Lung Cancer Surgery Revenue Market Forecast (2021-2025)
Figure 78. South America Lung Cancer Surgery Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Lung Cancer Surgery Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
肺がん診断及び治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Lung Cancer Diagnosis and Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Lung C…- 転移性大腸がん手術の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Metastatic Colorectal Cancer Surgery market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Metastat…
- がん検査/スクリーニングの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Cancer Testing/Screening market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Cancer Testing/Scree…
- 非侵襲的がん診断の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Noninvasive Cancer Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.7% in the forecast period of 2020 to 2025 and will expected to reach USD 127940 million by 2025, from USD 110450 million in 2019. The Nonin…
- 卵巣がんの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Ovarian Cancer market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 9.0% in the forecast period of 2020 to 2025 and will expected to reach USD 2382 million by 2025, from USD 1684.4 million in 2019. The Ovarian Cancer market r…